Our vision is to fundamentally transform prenatal diagnostics by making cell-free non-invasive prenatal testing (cfNIPT), chorionic villus sampling (CVS) and amniocentesis (Amnio) obsolete.

Our vision is to fundamentally transform prenatal diagnostics by making cell-free non-invasive prenatal testing (cfNIPT), chorionic villus sampling (CVS) and amniocentesis (Amnio) obsolete.

TECHNOLOGY

ARCEDI’s unique technology isolates fetal cells from maternal blood and uses them for genetic analysis

PRODUCT

With ‘EVITA TEST COMPLETE’ ARCEDI is the first company to provide genome-wide analysis of the fetus using circulating fetal cells

PATENTS

ARCEDI’s strong IP portfolio covers four patents and provides global protection through 2031

Latest news

Newsletter

Subscribe to our newsletter to get the latest updates on products and new scientific publications on ARCEDI technology.